Clinical Trials
4 trialsNCT01147536 2021-06-03
Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence
Agenus Inc.
Phase 2 Terminated
NCT00039000 2012-09-07
Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Agenus Inc.
Phase 3 Completed
NCT00126178 2012-09-07
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer
Agenus Inc.
Phase 3 Terminated
NCT00098085 2009-03-09
Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer
Agenus Inc.
Phase 2 Completed